Clinical Guideline for Precision Nuclear Medicine Diagnosis and Treatment of Neuroendocrine Neoplasms(2025 Edition)
10.12290/xhyxzz.2025-0610
- VernacularTitle:神经内分泌肿瘤核医学精准诊疗临床指南(2025版)
- Author:
Zhaohui ZHU
;
Sijin LI
;
Jing WANG
;
Yihebali CHI
;
Xuejuan WANG
- Collective Name:Chinese Society of Nuclear Medicine in Chinese Medical Association;Chinese Neuroendocrine Tumor Society in China International Exchange and Promotive Association for Medical and Health Care
- Publication Type:Journal Article
- Keywords:
neuroendocrine neoplasms;
precise nuclear medicine theranostics;
clinical guideline;
somatostatin receptor im-aging;
peptide receptor radionuclide therapy
- From:
Medical Journal of Peking Union Medical College Hospital
2025;16(4):855-866
- CountryChina
- Language:Chinese
-
Abstract:
In Western developed countries,precision nuclear medicine diagnosis and treatment for neuroendocrine neoplasms(NENs)have been widely adopted in clinical practice.Over the past two decades,China has made significant progress in both research and clinical application of nuclear medicine-based NENs management.With internationally approved diagnostic and therapeutic agents soon entering the Chinese market and the ongoing clinical trials of domestically developed innovative drugs,there is an urgent need to establish standardized diagnostic and treatment guideline.To address this,the Chinese Society of Nuclear Medicine and the Chinese Neuroendocrine Tumor Society have collaborated to develop the Clinical Guideline for Precision Nuclear Medicine Diagnosis and Treatment of Neuroendocrine Neoplasms(2025 Edition).The guideline integrates the latest research advances and international recommendations with China's clinical practice,aiming to standardize and optimize NENs management through nuclear medicine in China.
